| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| RF_0272 | RF_0701 | RF_0272 | RF_0701 | Antitoxin of toxin-antitoxin system Phd; Antitoxin component of a type II toxin-antitoxin (TA) system. | Toxin of toxin-antitoxin system; Containing PIN domain for nucleic acid binding. | 0.558 |
| RF_0272 | RF_0731 | RF_0272 | RF_0731 | Antitoxin of toxin-antitoxin system Phd; Antitoxin component of a type II toxin-antitoxin (TA) system. | Antitoxin of toxin-antitoxin system Phd; Antitoxin component of a type II toxin-antitoxin (TA) system. | 0.834 |
| RF_0272 | vapC2 | RF_0272 | RF_0095 | Antitoxin of toxin-antitoxin system Phd; Antitoxin component of a type II toxin-antitoxin (TA) system. | Toxin of toxin-antitoxin system; Toxic component of a type II toxin-antitoxin (TA) system. Has ssRNase activity. Upon expression in E.coli or S.cerevisiae inhibits growth in liquid culture; in S.cerevisiae its expression leads to apoptosis-like characteristics. Rapidly induces apoptosis (within 2 hours) upon microinjection into mouse fibroblasts (L929 line); pretreatment of cells with dexamethasone protects them. Probably contributes to host cell death if bacterial cell lysis occurs during host infection. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB2, its [...] | 0.583 |
| RF_0701 | RF_0272 | RF_0701 | RF_0272 | Toxin of toxin-antitoxin system; Containing PIN domain for nucleic acid binding. | Antitoxin of toxin-antitoxin system Phd; Antitoxin component of a type II toxin-antitoxin (TA) system. | 0.558 |
| RF_0701 | RF_0702 | RF_0701 | RF_0702 | Toxin of toxin-antitoxin system; Containing PIN domain for nucleic acid binding. | Antitoxin of toxin-antitoxin system Phd; Antitoxin component of a type II toxin-antitoxin (TA) system. | 0.862 |
| RF_0701 | RF_0731 | RF_0701 | RF_0731 | Toxin of toxin-antitoxin system; Containing PIN domain for nucleic acid binding. | Antitoxin of toxin-antitoxin system Phd; Antitoxin component of a type II toxin-antitoxin (TA) system. | 0.596 |
| RF_0701 | vapC2 | RF_0701 | RF_0095 | Toxin of toxin-antitoxin system; Containing PIN domain for nucleic acid binding. | Toxin of toxin-antitoxin system; Toxic component of a type II toxin-antitoxin (TA) system. Has ssRNase activity. Upon expression in E.coli or S.cerevisiae inhibits growth in liquid culture; in S.cerevisiae its expression leads to apoptosis-like characteristics. Rapidly induces apoptosis (within 2 hours) upon microinjection into mouse fibroblasts (L929 line); pretreatment of cells with dexamethasone protects them. Probably contributes to host cell death if bacterial cell lysis occurs during host infection. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB2, its [...] | 0.406 |
| RF_0702 | RF_0701 | RF_0702 | RF_0701 | Antitoxin of toxin-antitoxin system Phd; Antitoxin component of a type II toxin-antitoxin (TA) system. | Toxin of toxin-antitoxin system; Containing PIN domain for nucleic acid binding. | 0.862 |
| RF_0702 | vapC2 | RF_0702 | RF_0095 | Antitoxin of toxin-antitoxin system Phd; Antitoxin component of a type II toxin-antitoxin (TA) system. | Toxin of toxin-antitoxin system; Toxic component of a type II toxin-antitoxin (TA) system. Has ssRNase activity. Upon expression in E.coli or S.cerevisiae inhibits growth in liquid culture; in S.cerevisiae its expression leads to apoptosis-like characteristics. Rapidly induces apoptosis (within 2 hours) upon microinjection into mouse fibroblasts (L929 line); pretreatment of cells with dexamethasone protects them. Probably contributes to host cell death if bacterial cell lysis occurs during host infection. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB2, its [...] | 0.583 |
| RF_0731 | RF_0272 | RF_0731 | RF_0272 | Antitoxin of toxin-antitoxin system Phd; Antitoxin component of a type II toxin-antitoxin (TA) system. | Antitoxin of toxin-antitoxin system Phd; Antitoxin component of a type II toxin-antitoxin (TA) system. | 0.834 |
| RF_0731 | RF_0701 | RF_0731 | RF_0701 | Antitoxin of toxin-antitoxin system Phd; Antitoxin component of a type II toxin-antitoxin (TA) system. | Toxin of toxin-antitoxin system; Containing PIN domain for nucleic acid binding. | 0.596 |
| RF_0731 | vapC2 | RF_0731 | RF_0095 | Antitoxin of toxin-antitoxin system Phd; Antitoxin component of a type II toxin-antitoxin (TA) system. | Toxin of toxin-antitoxin system; Toxic component of a type II toxin-antitoxin (TA) system. Has ssRNase activity. Upon expression in E.coli or S.cerevisiae inhibits growth in liquid culture; in S.cerevisiae its expression leads to apoptosis-like characteristics. Rapidly induces apoptosis (within 2 hours) upon microinjection into mouse fibroblasts (L929 line); pretreatment of cells with dexamethasone protects them. Probably contributes to host cell death if bacterial cell lysis occurs during host infection. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB2, its [...] | 0.583 |
| ackA | pta | RF_0097 | RF_0096 | Acetate kinase; Catalyzes the formation of acetyl phosphate from acetate and ATP. Can also catalyze the reverse reaction; Belongs to the acetokinase family. | Phosphate acetyltransferase Pta. | 0.999 |
| ackA | vapB2 | RF_0097 | RF_0094 | Acetate kinase; Catalyzes the formation of acetyl phosphate from acetate and ATP. Can also catalyze the reverse reaction; Belongs to the acetokinase family. | Antitoxin of toxin-antitoxin system VapB; Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli or S.cerevisiae neutralizes the effect of cognate toxin VapC2, partially inhibits the RNase activity of VapC2. Belongs to the VapB family. | 0.497 |
| ackA | vapC2 | RF_0097 | RF_0095 | Acetate kinase; Catalyzes the formation of acetyl phosphate from acetate and ATP. Can also catalyze the reverse reaction; Belongs to the acetokinase family. | Toxin of toxin-antitoxin system; Toxic component of a type II toxin-antitoxin (TA) system. Has ssRNase activity. Upon expression in E.coli or S.cerevisiae inhibits growth in liquid culture; in S.cerevisiae its expression leads to apoptosis-like characteristics. Rapidly induces apoptosis (within 2 hours) upon microinjection into mouse fibroblasts (L929 line); pretreatment of cells with dexamethasone protects them. Probably contributes to host cell death if bacterial cell lysis occurs during host infection. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB2, its [...] | 0.497 |
| pta | ackA | RF_0096 | RF_0097 | Phosphate acetyltransferase Pta. | Acetate kinase; Catalyzes the formation of acetyl phosphate from acetate and ATP. Can also catalyze the reverse reaction; Belongs to the acetokinase family. | 0.999 |
| pta | vapB2 | RF_0096 | RF_0094 | Phosphate acetyltransferase Pta. | Antitoxin of toxin-antitoxin system VapB; Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli or S.cerevisiae neutralizes the effect of cognate toxin VapC2, partially inhibits the RNase activity of VapC2. Belongs to the VapB family. | 0.499 |
| pta | vapC2 | RF_0096 | RF_0095 | Phosphate acetyltransferase Pta. | Toxin of toxin-antitoxin system; Toxic component of a type II toxin-antitoxin (TA) system. Has ssRNase activity. Upon expression in E.coli or S.cerevisiae inhibits growth in liquid culture; in S.cerevisiae its expression leads to apoptosis-like characteristics. Rapidly induces apoptosis (within 2 hours) upon microinjection into mouse fibroblasts (L929 line); pretreatment of cells with dexamethasone protects them. Probably contributes to host cell death if bacterial cell lysis occurs during host infection. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB2, its [...] | 0.497 |
| vapB1 | vapB2 | RF_0457 | RF_0094 | Antitoxin of toxin-antitoxin system VapB; Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli neutralizes the effect of cognate toxin VapC1, partially inhibits the RNase activity of VapC1 in vitro. | Antitoxin of toxin-antitoxin system VapB; Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli or S.cerevisiae neutralizes the effect of cognate toxin VapC2, partially inhibits the RNase activity of VapC2. Belongs to the VapB family. | 0.416 |
| vapB1 | vapC2 | RF_0457 | RF_0095 | Antitoxin of toxin-antitoxin system VapB; Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli neutralizes the effect of cognate toxin VapC1, partially inhibits the RNase activity of VapC1 in vitro. | Toxin of toxin-antitoxin system; Toxic component of a type II toxin-antitoxin (TA) system. Has ssRNase activity. Upon expression in E.coli or S.cerevisiae inhibits growth in liquid culture; in S.cerevisiae its expression leads to apoptosis-like characteristics. Rapidly induces apoptosis (within 2 hours) upon microinjection into mouse fibroblasts (L929 line); pretreatment of cells with dexamethasone protects them. Probably contributes to host cell death if bacterial cell lysis occurs during host infection. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB2, its [...] | 0.442 |